ROTHBLATT MARTINE A sold UTHR
March 4, 2026 · Form 4 insider transaction
ROTHBLATT MARTINE A sold 40 shares of United Therapeutics Corporation at $497.05 per share, a transaction worth $19.9K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
40
Price
$497.05
Total value
$19.9K
InsiderROTHBLATT MARTINE A
RoleOfficer, Director
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMarch 4, 2026
Filing dateMarch 5, 2026
Shares owned after130
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 17, 2027; or (b) December 31, 2026.